Amendment To Manufacturing Agreement Sample Contracts

MusclePharm Corp – First Amendment to Manufacturing Agreement (May 11th, 2015)

This First Amendment (this "Amendment"), effective this second day of March 2015 ("Amendment Effective Date"), is made to the Manufacturing Agreement ("the Agreement") originally effective November 27, 2013 and is entered into by and between F.H.G. Corporation a Florida corporation having a principle place of business in Spring Hill, Tennessee, formerly doing business as "Integrity" but now doing business as "Capstone Nutrition" ("Capstone Nutrition") and MusclePharm Corporation ("MUSCLEPHARM"), a Nevada corporation having a principle place of business in Denver, Colorado.

Helix BioPharma Corp – Helix Biopharma Corp. Has Requested an Order From the Securities and Exchange Commission (The "Commission") Pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as Amended, Granting Confidential Treatment of Selected Portions of This Exhibit. Accordingly, the Confidential Portions Have Been Omitted From This Exhibit and Have Been Filed Separately With the Commission. Omitted Portions Are Indicated by "***". Third Amendment to Manufacturing Agreement (November 1st, 2011)

This third amendment agreement ("Third Amendment") is made this 1 day of October, 2010 by and between Helix Biopharma Corporation ("Helix"), a corporation organized and existing under the laws of Canada and having its principal offices located at 305 Industrial Parkway South, Unit 3, Aurora, Ontario, L4G 6X7, Contract Pharmaceuticals Limited Niagara ("CPL"), a corporation organized and existing under the laws of Delaware and having a place of business located at 100 Forest Avenue, Buffalo, New York, 14213, and Contract Pharmaceuticals Limited Canada ("CPL Canada"), a corporation organized and existing under the laws of Ontario, Canada and having its principal offices at 7600 Danbro Crescent, Mississauga, Ontario, Canada, L5N 6L6.

Confidential Treatment Requested Amendment to Manufacturing Agreement (August 5th, 2011)

This Amendment dated April 29, 2011 (this Amendment) to the Commercial Contract Manufacturing Agreement dated as of February 5, 2010, is entered into by and between Alliance Medical Products, Inc., a California corporation, (AMP) and Alimera Sciences, Inc. (CUSTOMER).

First Amendment to Manufacturing Agreement Between iRobot Corporation and Kin Yat Industrial Co. Ltd (December 29th, 2010)

This Amendment is made between iRobot Corporation (Buyer) and Kin Yat Industrial Co. Ltd., (Seller), and shall be effective as of the date last signed below.

First Amendment to Manufacturing Agreement Between iRobot Corporation and Kin Yat Industrial Co. Ltd (May 7th, 2010)

This Amendment is made between iRobot Corporation (Buyer) and Kin Yat Industrial Co. Ltd., (Seller), and shall be effective as of the date last signed below.

First Amendment to Manufacturing Agreement (February 16th, 2010)

This FIRST AMENDMENT TO MANUFACTURING AGREEMENT (First Amendment) is made May effective May 23, 2003, by and among Mannetech, Inc., a Texas corporation with its principal place of business at 600 S. Royal Lane #200, Coppell Texas (Mannetech) and Natural Alternatives International, Inc., a Delaware corporation with its principal place of business located at 1185 Linda Vista Drive, San Marcos, California (NAI).

Fourth Amendment to Manufacturing Agreement (February 16th, 2010)

THIS FOURTH AMENDMENT TO MANUFACTURING AGREEMENT (this Amendment) is effective as of January 1, 2008, by and between NATURAL ALTERNATIVES INTERNATIONAL, INC. (NAI), MANNATECH, INCORPORATED (MANNATECH US), and MANNATECH SWISS INTERNATIONAL GmbH (MANNATECH SWISS).

Second Amendment to Manufacturing Agreement (February 16th, 2010)

This SECOND AMENDMENT TO MANUFACTURING AGREEMENT (Second Amendment) is made effective July 1, 2003, by and among Mannatech, Inc., a Texas corporation with its principal place of business at 600 S. Royal Lane #200, Coppell Texas (Mannatech) and Natural Alternatives International, Inc., a Delaware corporation with its principal place of business located at 1185 Linda Vista Drive, San Marcos, California (NAI).

Third Amendment to Manufacturing Agreement (February 16th, 2010)

This THIRD AMENDMENT TO MANUFACTURING AGREEMENT (Third Amendment) is made effective July 1, 2004, by and among Mannatech, Inc., a Texas corporation with its principal place of business at 600 S. Royal Lane #200, Coppell Texas (Mannatech) and Natural Alternatives International, Inc., a Delaware corporation with its principal place of business located at 1185 Linda Vista Drive, San Marcos, California (NAI).

Third Amendment to Manufacturing Agreement (September 22nd, 2009)

This Third Amendment to Manufacturing Agreement, dated as of January 1, 2009 (this Amendment), is made and entered into by and between Microtune (Texas), L.P., a Texas limited partnership, located at 2201 10th Street, Plano, Texas 75074 (Microtune or Buyer) and Ionics EMS, Inc. (Ionics or Company).

Second Amendment to Manufacturing Agreement (May 2nd, 2008)

This Second Amendment to Manufacturing Agreement, dated as of January 1, 2008 (this Amendment), is made and entered into by and between Microtune (Texas), L.P., a Texas limited partnership, located at 2201 10th Street, Plano, Texas 75074 (Microtune or Buyer) and Ionics EMS, Inc. (Ionics or Company).

Amendment to Manufacturing Agreement (February 11th, 2008)

The Manufacturing Agreement between Alcon Pharmaceuticals Ltd. (Alcon) and Lifecore Biomedical, Inc. dated effective on January 1, 2006, is hereby amended as follows:

Second Amendment to Manufacturing Agreement and Award Letter (November 9th, 2005)

THIS SECOND AMENDMENT (the Second Amendment) to the Manufacturing Agreement made on and as of May 20, 2002, as amended, and the Award Letter made on and as of May 20, 2002 (collectively, the Agreement) is hereby made and entered into as of September 16, 2005 (the Second Amendment Effective Date), by and between DOT HILL SYSTEMS CORPORATION, a Delaware corporation (hereinafter Dot Hill) whose principal place of business is 6305 El Camino Real, Carlsbad, California 92009, and SOLECTRON CORPORATION, a Delaware corporation, on behalf of itself and its subsidiaries and affiliates, including but not limited to, Solectron Technology Singapore Pte. Ltd., Solectron Europe B.V. and other Offshore Business Headquarters (OBHQs), whose principal place of business is 847 Gibraltar Drive, Milpitas, California 95035 (hereinafter Supplier).

Auxilium Pharmaceuticals, Inc. – Third Amendment to Manufacturing Agreement Between DPT Laboratories, Ltd. And Auxilium Pharmaceuticals, Inc. (September 20th, 2005)

Whereas, DPT Laboratories, Ltd. (DPT) and Auxilium Pharmaceuticals, Inc. (the COMPANY) entered into a Manufacturing Agreement dated April 23, 2002, followed by the First and Second Amendments (the Manufacturing Agreement) relating to the manufacture of COMPANYS testosterone product (the Product);

First Amendment to Manufacturing Agreement and Award Letter (August 9th, 2005)

THIS FIRST AMENDMENT (the First Amendment) to the Manufacturing Agreement made on and as of May 20, 2002, (the Agreement) and related Award Letter made on and as of May 20, 2002 to the Agreement (the Award Letter) is hereby made and entered into as of March 10, 2005 (the First Amendment Effective Date), by and between DOT HILL SYSTEMS CORPORATION, a Delaware corporation, (hereinafter Dot Hill) whose principal place of business is 6305 El Camino Real, Carlsbad, California 92009, and SOLECTRON CORPORATION, a Delaware Corporation, on behalf of itself and its subsidiaries and affiliates, including but not limited to, Solectron Technology Singapore Pte. Ltd. and Solectron Europe B.V. and any other Offshore Business Headquarters (OBHQs), with its principal place of business at 847 Gibraltar Drive, Milpitas, California 95035 (hereinafter Supplier).

Charles & Colvard – Re: Amendment to Manufacturing Agreement Dear Klaus: (November 9th, 2004)

This letter sets forth the agreement of Charles & Colvard, Ltd. (C&C) and Reeves Park, Inc. (Buyer) to amend the standard Terms and Conditions as set forth in the Manufacturing Agreement dated August 12, 2004 between C&C and Buyer. Notwithstanding any provision of such Terms and Conditions, by mutual agreement C&C and Buyer may extend various terms to Buyer and payment shall be due in full pursuant to the terms as set out on the applicable C&C invoice to Buyer.

Amendment to Manufacturing Agreement (August 23rd, 2004)

THIS AMENDMENT TO MANUFACTURING AGREEMENT (this Amendment) is made this 1st day of October, 2003, by and between CP Kelco U.S., Inc. (CP Kelco) and Martek Biosciences Boulder Corporation (Martek).

Auxilium Pharmaceuticals, Inc. – First Amendment to Manufacturing Agreement Between DPT Laboratories, Ltd. And Auxilium Pharmaceuticals, Inc. (July 2nd, 2004)

This First Amendment to Manufacturing Agreement (First Amendment) between DPT Laboratories, Ltd. (DPT) and Auxilium Pharmaceuticals, Inc. (COMPANY) is made this 28th day of May, 2002.

Auxilium Pharmaceuticals, Inc. – First Amendment to Manufacturing Agreement Between DPT Laboratories, Ltd. And Auxilium Pharmaceuticals, Inc. (April 21st, 2004)

This First Amendment to Manufacturing Agreement (First Amendment) between DPT Laboratories, Ltd. (DPT) and Auxilium Pharmaceuticals, Inc. (COMPANY) is made this 28th day of May, 2002.

Amendment to Manufacturing Agreement (January 29th, 2004)

THIS AMENDMENT TO MANUFACTURING AGREEMENT (this Amendment) is made this 1st day of October, 2003, by and between CP Kelco U.S., Inc. (CP Kelco) and Martek Biosciences Boulder Corporation (Martek).

Aaipharma Inc – First Amendment to Manufacturing Agreement (December 15th, 2003)

This First Amendment to Manufacturing Agreement (this Amendment) is made by and between ELAN PHARMA INTERNATIONAL LIMITED, a private limited company organized under the laws of the Republic of Ireland (Elan) and ROXANE LABORATORIES, INC., a Delaware corporation (Roxane) and is effective only upon the consummation of the closing (the Amendment Effective Date) under that certain Asset Purchase Agreement dated as of October 22, 2003 by and among Elan, Elan Pharmaceuticals, Inc. and aaiPharma Inc. and only in the event such closing occurs on or before March 1, 2004.

Com21 – Amendment to Manufacturing Agreement (April 1st, 2002)

This Amendment to Manufacturing Agreement (this "Agreement") is made as of March 29, 2002 (the "Effective Date") by and between Flextronics Malaysia SDN BHD (the "Supplier") and Com21, Inc. (the "Customer").